DTIL SCHEDULE 13G/A: SEC filing
Lynx1 Capital Management LP
Filed with the SEC on · accession 0000902664-26-004574
DTIL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Lynx1 Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 2,758,215 shares, or 9.9%, of Precision BioSciences common stock as of September 30, 2026. The stock moved -3.8% by the first close after the filing.
Summary of the filing
Lynx1 Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 2,758,215 shares, or 9.9%, of Precision BioSciences common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.
Key details
How DTIL stock reacted
Close before
$7.57
Nov 13, 2026
First close after
-3.77%
$7.28
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DTIL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DTIL?
Click hereFrequently asked questions
What did DTIL file with the SEC on Nov 16, 2026?
DTIL filed a SCHEDULE 13G/A (SEC filing). Lynx1 Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 2,758,215 shares, or 9.9%, of Precision BioSciences common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did DTIL stock react to this filing?
DTIL closed at $7.57 before the filing and $7.28 on Nov 16, 2026 (-3.77%).
Other DTIL SEC filings
- 8-K · Secondary offeringNov 9, 2026
- 8-K · Secondary offeringNov 6, 2026
- 424B5 · Secondary offeringNov 6, 2026
- 8-K · Fda approvalNov 5, 2026
- 8-K · SEC filingNov 3, 2026
- 10-Q · SEC filingNov 3, 2026
- SCHEDULE 13G/A · SEC filingNov 3, 2026
- SCHEDULE 13G · SEC filingOct 27, 2026
- 8-K · SEC filingAug 24, 2026
- SCHEDULE 13G/A · SEC filingAug 24, 2026
Get alerts when DTIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days